S. Laperche

J. Pawlotsky, F. Roudot-thoraval, S. Chevaliez, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

J. Pawlotsky, S. Chevaliez, S. Laperche, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Outbreak of Hepatitis C Virus Infection in a Hemodialysis Unit: Potential Transmission by the Hemodialysis Machine?

J. Desenclos, E. Delarocque-Astagneau, S. Laperche, 2002, Infection Control & Hospital Epidemiology.

Low rate of RNAemia in blood donations collected during the first wave of COVID‐19 in France

P. Gallian, V. Barlet, P. Morel, 2022, Transfusion.

Improving platelet transfusion safety: biomedical and technical considerations.

P. Morel, B. Pozzetto, O. Garraud, 2016, Blood transfusion = Trasfusione del sangue.

Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France

M. Jauffret-Roustide, P. Tiberghien, G. Woimant, 2017, Transfusion.

Transfusion sanguine : en toute sécurité infectieuse

P. Morel, B. Pozzetto, J. Lefrère, 2015 .

Surveillance of Transfusion-Transmissible Infections

S. Kleinman, L. Brant, S. O’Brien, 2011, Transfusion Medicine Reviews.

Blood safety and nucleic acid testing in Europe.

S. Laperche, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Les complications de la transfusion sanguine

Y. Mahjoub, E. Zogheib, H. Dupont, 2019, Anesthésie & Réanimation.

Failures in the detection of HIV p24 antigen with the Determine HIV-1/2 Ag/Ab Combo rapid test.

S. Laperche, J. Plantier, Lionel Leballais, 2012, The Journal of infectious diseases.

Noncompliance to blood donor selection criteria by men who have sex with men – Complidon 2017, France

P. Morel, C. Pelat, S. Laperche, 2020, Vox sanguinis.

The potential of viral metagenomics in blood transfusion safety.

V. Sauvage, S. Laperche, L. Boizeau, 2017, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay.

X. de Lamballerie, P. Marcellin, J. Pawlotsky, 2000, Journal of virological methods.

Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios

S. Kleinman, M. Busch, S. Laperche, 2015, Transfusion.

High levels of serum hepatitis B virus DNA in patients with ‘anti‐HBc alone’: role of HBsAg mutants

P. Sogni, A. Rosenberg, O. Launay, 2011, Journal of viral hepatitis.

Blood safety strategies for human T‐cell lymphotropic virus in Europe

S. Laperche, J. Pillonel, B. Worms, 2009, Vox sanguinis.

Performance of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA Quantification

Jean-Michel Pawlotsky, J. Pawlotsky, S. Chevaliez, 2008, Journal of Clinical Microbiology.

Performance of Version 2.0 of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA Quantification

J. Pawlotsky, S. Chevaliez, C. Hézode, 2010, Journal of Clinical Microbiology.

Performance of Version 2.0 of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA Quantiﬁcation (cid:1)

J. Pawlotsky, S. Chevaliez, C. Hézode, 2010 .

Impact of hepatitis B virus genotypes and surface antigen variants on the performance of HBV real time PCR quantification.

V. Thibault, A. Roque-Afonso, S. Laperche, 2009, Journal of virological methods.

Should cellular therapy products be tested for human herpesvirus 8?

J. Lefrère, S. Laperche, N. Guillaume, 2007, Transfusion.

Group O Human Immunodeficiency Virus Type 1 Infection That Escaped Detection in Two Immmunoassays

A. Moreau, S. Brunet, S. Laperche, 2006, Journal of Clinical Microbiology.

Comparative Performance of Three Rapid HBsAg Assays for Detection of HBs Diagnostic Escape Mutants in Clinical Samples

S. Laperche, C. Hamon, A. Servant‐Delmas, 2015, Journal of Clinical Microbiology.

Screening for Human Immunodeficiency Virus Infection by Use of a Fourth-Generation Antigen/Antibody Assay and Dried Blood Spots: In-Depth Analysis of Sensitivity and Performance Assessment in a Cross-Sectional Study

G. Peytavin, S. Laperche, C. Sommen, 2019, Journal of Clinical Microbiology.

Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France

P. Gallian, P. Morel, S. Laperche, 2022, Vox sanguinis.

A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries

E. Murphy, P. Zacharias, J. Lefrère, 2014, Vox sanguinis.

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas® HBV Test for Use on the Cobas® 4800 System

J. Pawlotsky, S. Chevaliez, S. Laperche, 2021, Microorganisms.

No Evidence of HCV-Assisted HDV Propagation in a Large Cohort of Hepatitis C Positive Blood Donors.

C. Sureau, S. Laperche, Pierre Cappy, 2020, The Journal of infectious diseases.

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

J. Huraux, R. Poupon, P. Opolon, 1993, Journal of hepatology.

[Assessment of a transfusion emergent risk: the case of HEV].

P. Gallian, R. Djoudi, S. Laperche, 2014, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose

J. Allain, D. Candotti, S. Laperche, 2018, Gut.

Occult hepatitis B infection and transfusion-transmission risk.

D. Candotti, S. Laperche, L. Boizeau, 2017, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.

J. Lefrère, J. Allain, D. Candotti, 2005, Blood.

Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis

S. Laperche, P. Chrétien, C. Johanet, 1992, Hepatology.

Transfusion risk associated with recent arbovirus outbreaks in French Polynesia

H. Mallet, S. Laperche, S. Lastère, 2019, Vox sanguinis.

Impact on blood safety of the last arboviruses outbreaks in French Polynesia (2012-2018).

H. Mallet, S. Laperche, S. Lastère, 2019, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Analysis of the 5′ Noncoding Region versus the NS5b Region in Genotyping Hepatitis C Virus Isolates from Blood Donors in France

P. Gallian, P. de Micco, S. Laperche, 2006, Journal of Clinical Microbiology.

Use of an Anti-Hepatitis C Virus (HCV) IgG Avidity Assay To Identify Recent HCV Infection

C. Gaudy-Graffin, A. Goudeau, S. Laperche, 2010, Journal of Clinical Microbiology.

Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation

F. Roudot-thoraval, J. Lefrère, S. Laperche, 2008, Vox sanguinis.

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003

Indira Hewlett, Ludo Muylle, Susan L. Stramer, 2005 .

Limits of sequencing and phylogenetic analysis to assess B19V transmission by single‐donor blood component

J. Lefrère, S. Laperche, É. Pélissier, 2011, Vox sanguinis.

[Quantitative estimate of the risk of blood donation contamination by infectious agents].

P. Bernillon, S. Laperche, C. Brouard, 2009, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Transfusion-associated hazards: A revisit of their presentation.

O Garraud, C. Aloui, S. Laradi, 2018, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Fifteen years of Nucleic Acid Testing in France: Results and lessons.

P. Tiberghien, S. Laperche, J. Pillonel, 2017, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Challenges in transfusion-transmitted infection screening in Sub-Saharan Africa.

D. Candotti, S. Laperche, Claude Tagny-Tayou, 2021, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Transfusion safety on the African continent: an international quality control of virus testing in blood banks

E. Murphy, J. Lefrère, S. Laperche, 2009, Transfusion.

A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases

V. Barlet, P. Morel, F. Lunel, 2008, Transfusion.

Efficacy of HCV core antigen detection during the preseroconversion period

S. Laperche, A. Couroucé, F. Bouchardeau, 2000, Transfusion.

Reducing risks of Transfusion‐transmitted infections in a resource‐limited hospital‐based blood bank: the case of the Yaoundé University Teaching Hospital, Cameroon

E. Murphy, S. Laperche, D. Mbanya, 2016, ISBT science series.

An incident case-control study of modes of hepatitis C virus transmission in France.

J. Desenclos, E. Delarocque-Astagneau, S. Laperche, 2007, Annals of epidemiology.

Risk factors for human immunodeficiency virus among blood donors in Cameroon: evidence for the design of an Africa‐specific donor history questionnaire

E. Murphy, S. Laperche, D. Mbanya, 2017, Transfusion.

The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France

C. Pelat, P. Tiberghien, B. Coignard, 2020, Transfusion.

Proficiency Testing of Viral Marker Screening in African Blood Centers — Seven African Countries, 2017

E. Murphy, J. Hilton, A. De, 2019, MMWR. Morbidity and mortality weekly report.

Updated characteristics of blood services, donors and blood products in 11 French‐speaking African countries

E. Murphy, S. Laperche, C. Tagny, 2018, Vox sanguinis.

The infectious risks in blood transfusion as of today - A no black and white situation.

B. Pozzetto, O. Garraud, S. Laperche, 2016, Presse medicale.

Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.

E. Murphy, J. Lefrère, S. Laperche, 2014, Journal of virological methods.

Estimate of the residual risk of transfusion‐transmitted human immunodeficiency virus infection in sub‐Saharan Africa: a multinational collaborative study

J. Lefrère, S. Laperche, S. Diop, 2011, Transfusion.

Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays.

C. Brennan, G. Schochetman, S. Laperche, 2004, Journal of virological methods.

The use of the GeeniusTM HIV‐1/2 Rapid confirmatory test for the enrolment of patients and blood donors in the WHO Universal Test and Treat Strategy in Cameroon, Africa

E. Murphy, S. Laperche, C. Kouanfack, 2020, Vox sanguinis.

Reduction of the risk of transfusion‐transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon

E. Murphy, J. Lefrère, S. Laperche, 2011, Transfusion.

The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection.

S. Laperche, V. Lemée, J. Plantier, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation

P. Morel, P. Tiberghien, V. Enouf, 2020, Blood.

Antimitochondrial antibodies in the antiphospholipid syndrome

O. Meyer, S. Laperche, C. Johanet, 1995, Clinical reviews in allergy & immunology.

Sensitivity of hepatitis B virus DNA transcription‐mediated amplification testing in hepatitis B surface antigen–positive blood donations

S. Laperche, M. Mercier, A. Girault, 2006, Transfusion.

Molecular Epidemiology and Clinical Characteristics of Hepatitis B Identified through the French Mandatory Notification System

E. Delarocque-Astagneau, V. Thibault, S. Laperche, 2013, PloS one.

Autoantibodies to Phospholipids and to the Coagulation Proteins in AIDS

W. Rozenbaum, C. Marbot, S. Laperche, 1997, Thrombosis and Haemostasis.

Performance of HBsAg quantification assays for detection of Hepatitis B virus genotypes and diagnostic escape-variants in clinical samples.

V. Thibault, A. Roque-Afonso, S. Laperche, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).

S. Laperche, J. Pillonel, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Determination of hepatitis B virus subtypes by an enzyme immunoassay method using monoclonal antibodies to type‐specific epitopes of HBsAg

S. Laperche, A. Couroucé, A. Girault, 2001, Journal of viral hepatitis.

Insights on 21 Years of HBV Surveillance in Blood Donors in France

P. Morel, D. Candotti, S. Laperche, 2022, Viruses.

National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France

S. Laperche, J. Pillonel, M. Mercier, 2010, Transfusion.

[Results of a novel real-time PCR, sequence analysis, Inno-LiPA line probe assays in the detection of hepatitis B virus G1896A precore mutation in French blood donors].

S. Laperche, F. Lunel-Fabiani, A. Ducancelle, 2011, Pathologie-biologie.

Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples.

C. Sureau, C. Alloui, S. Laperche, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Sensitivities of Four New Commercial Hepatitis B Virus Surface Antigen (HBsAg) Assays in Detection of HBsAg Mutant Forms

A. Roque-Afonso, S. Laperche, E. Dussaix, 2006, Journal of Clinical Microbiology.

[Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].

S. Laperche, J. Pillonel, 2004, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Early MinION™ nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples

Mathias Vandenbogaert, D. Candotti, V. Sauvage, 2018, PloS one.

A Highly Prevalent Polymorphism in the Core Region Impairs Quantification of Hepatitis B Virus (HBV) by the cobas TaqMan HBV Assay

S. Chevaliez, V. Thibault, S. Laperche, 2020, Journal of Clinical Microbiology.

Increasing prevalence of HDV/HBV infection over 15 years in France.

P. Gallian, S. Laperche, F. Le Gal, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.

E. Murphy, D. Candotti, S. Laperche, 2019, Blood transfusion = Trasfusione del sangue.

International forum on Occult hepatitis B infection and transfusion safety

P. Gallian, L. Jarvis, S. Sauleda, 2019, Vox sanguinis.

Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi‐subgenotype A3, genotype E, and mixed infections

M. Sanou, J. Allain, D. Candotti, 2016, Journal of medical virology.

Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains

D. Candotti, S. Laperche, Lunan Wang, 2019, Emerging microbes & infections.

A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection

J. Lefrère, S. Laperche, F. Bouchardeau, 2003, Transfusion.

Serological and Molecular Diagnosis of Hepatitis Delta Virus Infection: Results of a French National Quality Control Study

D. Roulot, S. Laperche, F. Le Gal, 2014, Journal of Clinical Microbiology.

Could Droplet Digital PCR Be Used Instead of Real-Time PCR for Quantitative Detection of the Hepatitis B Virus Genome in Plasma?

V. Thibault, S. Laperche, N. Désiré, 2014, Journal of Clinical Microbiology.

Alternative hepatitis B virus DNA confirmatory algorithm identified occult hepatitis B virus infection in Chinese blood donors with non-discriminatory nucleic acid testing.

D. Candotti, S. Laperche, Tingting Li, 2020, Blood transfusion = Trasfusione del sangue.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Two cases of transfusion‐transmitted hepatitis B virus (HBV) infection in a low‐endemic country before implementation of HBV nucleic acid testing

S. Laperche, S. Hantz, S. Alain, 2013, Transfusion.

In Reply

S. Laperche, J. Pillonel, M. Maniez, 2009 .

Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay

P. de Micco, J. Pawlotsky, J. Lefrère, 2007, Journal of Clinical Microbiology.

Comparison of Hepatitis C Virus NS5b and 5′ Noncoding Gene Sequencing Methods in a Multicenter Study

J. Pawlotsky, G. Duverlie, J. Izopet, 2005, Journal of Clinical Microbiology.

Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations.

Helen H. Lee, J. Pawlotsky, J. Allain, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Genotype 4 hepatitis C virus: Beware of false‐negative RNA detection

V. Thibault, S. Laperche, S. Akhavan, 2011, Hepatology.

Genetic Diversity within Human Erythroviruses: Identification of Three Genotypes

S. Laperche, J. Meritet, F. Lallemand, 2002, Journal of Virology.

Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil

S. Kashima, D. Covas, S. Slavov, 2019, Journal of medical virology.

Etude par les fragments de restriction (RFLP) du polymorphisme de l'ADN en criminologie : analyses quantitative et qualitative à partir de sang et de sperme séchés sur différents supports

P. Rouger, S. Laperche, C. Salmon, 1991 .

Epidemiology of Human Parvovirus 4 Infection in Sub-Saharan Africa

O. Pybus, P. Simmonds, M. Lebreton, 2010, Emerging Infectious Diseases.

Transfusion of HIV‐infected blood products despite highly sensitive nucleic acid testing

V. Barlet, P. Tiberghien, S. Laperche, 2019, Transfusion.

Prevalence of Borna disease virus RNA in populations at high or low risk for blood‐borne infections

J. Lefrère, R. Girot, S. Laperche, 2004, Transfusion.

Genotypes Erythroviruses : Identification of Three Genetic Diversity within Human

S. Laperche, J. Meritet, F. Lallemand, 2002 .

Human parvovirus 4 infection in low‐ and high‐risk French individuals

P. Simmonds, J. Lefrère, S. Laperche, 2014, Transfusion.

Human parvovirus 4 in recipients of cellular products and in blood donors: epidemiologic similarity with B19 parvovirus

J. Lefrère, R. Girot, S. Laperche, 2009, Transfusion.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?

S. Laperche, Syria Laperche, Thoai Duong Ly, 2007, Journal of virological methods.

HIV-1 and HCV infections among antibody-negative blood donors.

P. Hervé, S. Laperche, J. Pillonel, 2004, The New England journal of medicine.

Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors

P. Gallian, P. de Micco, H. Attoui, 2008, Journal of medical virology.

Repository of blood samples from recipients of red blood cell transfusions in France

J. Lefrère, R. Girot, S. Laperche, 2007, Transfusion.

Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs

D. Candotti, V. Sauvage, S. Laperche, 2018, Annals of Internal Medicine.

GB Virus type C/HGV markers in HCV RNA‐positive French blood donors: correlation with HCV genotypes and risk factors

S. Laperche, J. Pillonel, A. Couroucé, 2000, Transfusion.

Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.

S. Laperche, A. Couroucé, A. Kolko, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Genetic diversity of human erythroviruses. Consequences on infectious safety of plasma derivatives].

J. Lefrère, S. Laperche, M. Mercier, 2009, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[Genetic diversity of human Erythroviruses].

J. Lefrère, S. Laperche, M. Mercier, 2009, Pathologie-biologie.

Building capacities in research for blood services in Africa.

E. Murphy, I. Bates, S. Laperche, 2021, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

HIV transmission network analysis allows identifying unreported risk factors in HIV‐positive blood donors in France

P. Tiberghien, L. Meyer, A. Chaillon, 2021, Transfusion.

Noncompliance with blood donor selection criteria ‐ Complidon 2017, France

C. Pelat, G. Woimant, S. Laperche, 2019, Transfusion.

Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in France.

P. Gallian, P. Morel, D. Candotti, 2021, Blood transfusion = Trasfusione del sangue.

Trends in residual risk of transfusion‐transmitted viral infections in France between 1992 and 2000

J. Desenclos, C. Saura, S. Laperche, 2002, Transfusion.

[Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003].

S. Laperche, J. Pillonel, A. Girault, 2005, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[Relevance of safety measures to avoid HTLV transmission by transfusion in 2014].

S. Laperche, J. Pillonel, 2014, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Accuracy assessment of total or IgG Immunoglobulin to hepatitis A virus tests around immunity threshold.

F. Griscelli, S. Chevaliez, A. Roque-Afonso, 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Characterization of hepatitis B viral forms from patient plasma using velocity gradient: Evidence for an excess of capsids in fractions enriched in Dane particles

P. Gripon, V. Thibault, S. Laperche, 2022, PloS one.

Development and clinical validation of loop-mediated isothermal amplification (LAMP) assay to diagnose high HBV DNA levels in resource-limited settings.

A. Seck, R. Bercion, A. Dublineau, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The contribution of more sensitive hepatitis B surface antigen assays to detecting and monitoring hepatitis B infection.

D. Candotti, V. Thibault, S. Laperche, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Early Detection of Human Immunodeficiency Virus Infection Using Third- and Fourth-Generation Screening Assays

S. Laperche, T. Ly, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Multicenter performance evaluation of the Elecsys HCV Duo immunoassay.

M. Vermeulen, S. Laperche, Korbinian Bronner, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation

M. Deschaseaux, P. Morel, P. Rouger, 2003, Transfusion.

International Forum on Occult hepatitis B infection and transfusion safety

P. Gallian, L. Jarvis, S. Sauleda, 2019, Vox sanguinis.

Anti‐HBc‐nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults

J. Allain, D. Candotti, S. Laperche, 2022, Journal of viral hepatitis.

High prevalence of cyclovirus Vietnam (CyCV-VN) in plasma samples from Madagascan healthy blood donors.

Mathias Vandenbogaert, V. Sauvage, V. Caro, 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France

J. Izopet, J. Lefrère, F. Abravanel, 2016, Journal of viral hepatitis.

Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections

J. Desenclos, P. Bernillon, S. Brunet, 2008, Transfusion.

Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.

E. Murphy, D. Candotti, S. Laperche, 2019, Blood transfusion = Trasfusione del sangue.

[Assessment of a transfusion emergent risk: the case of HEV].

P. Gallian, R. Djoudi, S. Laperche, 2014, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Report of the first French Anticardiolipin Antibodies Standardization Workshop

O. Meyer, S. Laperche, N. Abuaf, 1995, Clinical reviews in allergy and immunology.

Are International Units of Anti-HBs Antibodies Always Indicative of Hepatitis B Virus Neutralizing Activity?

M. Ungeheuer, C. Sureau, C. Gaudy-Graffin, 2023, Vaccines.

Nucleic acid amplification testing detection of an HIV‐1 infection in a blood donor during the preseroconversion window period

D. Neau, H. Fleury, S. Laperche, 2007, Transfusion medicine.

Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan

L. Queirós, S. Sauleda, Toshiki Watanabe, 2017, Journal of Clinical Microbiology.

Reduced neutralizing antibody potency of COVID‐19 convalescent vaccinated plasma against SARS‐CoV‐2 Omicron variant

P. Gallian, P. Morel, P. Tiberghien, 2022, Vox sanguinis.

GB virus type C/hepatitis G virus infection in French blood donors with anti‐NS5 isolated reactivities by recombinant immunoblot assay for hepatitis C virus

J. Coste, S. Laperche, A. Couroucé, 1999, Transfusion.

Interpretation of Real-Time PCR Results for Hepatitis C Virus RNA When Viral Load Is Below Quantification Limits

J. Pawlotsky, G. Duverlie, J. Izopet, 2011, Journal of Clinical Microbiology.

Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load

J. Lefrère, S. Laperche, F. Bouchardeau, 2004, Vox Sanguinis.

Acute HCV infection detected in a blood donor by NAT

J. Izopet, J. Coste, J. Schved, 2003, Transfusion.

[Application of molecular biology to blood transfusion safety: the nucleic acid testing].

V. Barlet, J. Coste, S. Laperche, 2003, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men

P. Tiberghien, S. Laperche, J. Pillonel, 2023, Vox Sanguinis.

High rate of hepatitis C virus and human immunodeficiency virus false‐positive results in serologic screening in sub‐Saharan Africa: adverse impact on the blood supply

E. Murphy, D. Candotti, V. Sauvage, 2019, Transfusion.

Characterization of hepatitis B viral forms from patient plasma using velocity gradient: evidence for an excess of capsids in Dane particles enriched fractions

P. Gripon, V. Thibault, S. Laperche, 2022, bioRxiv.

Cas groupés d'infections aiguës par le virus de l'hépatite B liés à des actes d'acupuncture, Languedoc-Roussillon (France), 2008

B. Coignard, S. Laperche, D. Antona, 2011 .

Seroconversion to hepatitis C virus alternate reading frame protein during acute infection

J. Pawlotsky, J. Lavergne, H. Wedemeyer, 2009, Hepatology.

No Evidence of Hepatitis C Virus (HCV)–Assisted Hepatitis D Virus Propagation in a Large Cohort of HCV-Positive Blood Donors

C. Sureau, S. Laperche, Pierre Cappy, 2020, The Journal of Infectious Diseases.

Genotype 4 hepatitis C virus: Beware of false‐negative RNA detection

V. Thibault, S. Laperche, S. Akhavan, 2011, Hepatology.

[Quantitative estimate of the risk of blood donation contamination by infectious agents].

P. Bernillon, S. Laperche, H. de Valk, 2009, Transfusion Clinique et Biologique.

Definition of emerging infectious diseases

S. Laperche, 2011, ISBT science series.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Seroconversion to hepatitis C virus alternate reading frame protein during acute infection

J. Pawlotsky, J. Lavergne, H. Wedemeyer, 2009, Hepatology.

Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance.

P. Gallian, S. Laperche, P. Richard, 2023, Vox sanguinis.

Multinational assessment of blood‐borne virus testing and transfusion safety on the African continent

S. Laperche, 2013, Transfusion.

The infectious risks in blood transfusion as of today - A no black and white situation.

B. Pozzetto, O. Garraud, S. Laperche, 2016, Presse medicale.

[Relevance of safety measures to avoid HTLV transmission by transfusion in 2014].

S. Laperche, J. Pillonel, S. Laperche, 2014, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[Blood transfusion: control of infectious risks].

P. Morel, B. Pozzetto, J. Lefrère, 2015, Presse medicale.

Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination

J. Pawlotsky, G. Duverlie, J. Izopet, 2007, Journal of Clinical Microbiology.

Increasing prevalence of HDV/HBV infection over 15 years in France.

P. Gallian, S. Laperche, F. Le Gal, 2014, Journal of Clinical Virology.

Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives.

P. Gallian, I. Dupont, P. Morel, 2022, Blood transfusion = Trasfusione del sangue.